Ballard returns to sales growth in first quarter
This article was originally published in Clinica
Executive Summary
Ballard, a US manufacturer of critical and alternate care disposables, has returned to rising turnover in the first quarter of fiscal 1995 when sales increased 15% compared with the previous year. Ballard had described fiscal 1994 as a "difficult year in some respects". Sales were flat compared with 1993, partly because of the decision in mid-1994 to restructure the company's distribution system shifting from specialty dealers to larger, general line dealers.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.